STOCKHOLDERS' EQUITY |
3 Months Ended |
|---|---|
Mar. 31, 2023 | |
| Stockholders' Equity Note [Abstract] | |
| STOCKHOLDERS' EQUITY |
NOTE 9 — STOCKHOLDERS' EQUITY
As of December. 31, 2022, the Company had 19,107,793 exercisable common warrants, with a contractual exercise price of $0.80 per warrant, expiring five years from initial issuance in October 2020. During the three months ended March 31, 2023, a total of 4,517,427 common warrants were exercised. The Company received $0.80 per warrant, with total proceeds received from these exercises being $3,613,941. As of March. 31, 2023 there remained 14,590,366 exercisable common warrants.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|